Thinzar Min

Dr Thinzar Min is a Clinical Senior Lecturer and Consultant Physician in Diabetes and Endocrinology at Swansea University Medical School, affiliated with Swansea Bay University Health Board. She holds roles as Audit Lead and Morbidity/Mortality Review Lead at Singleton Hospital. Her academic background includes an MD from Swansea University (2017) and an MSc (Diabetes) from Cardiff University (2014). She specializes in metabolic surgery outcomes, diabetes management, and clinical trials, with a focus on bariatric surgery’s long-term effects and novel therapies for diabetes complications.

Education:

• Bachelor of Medicine (2005), Yangon, Myanmar
• MSc (Diabetes) with distinction, Cardiff University (2014)
• MD (Swansea University Medical School, 2017)

Research Interests:

Her research focuses on metabolic outcomes of bariatric surgery, GLP-1 receptor agonists, diabetes technology (e.g., continuous glucose monitoring), and comorbidities like nonalcoholic fatty liver disease. Recent work explores interventions for acute frailty and liver disease screening in surgical patients.

Publications Overview:

Dr Min’s 15 most recent articles (2019-2025) emphasize clinical trials of diabetes therapies, bariatric surgery outcomes, and technology-driven management strategies. Key themes include GLP-1 agonists, FreeStyle Libre monitoring, and bidirectional links between diabetes and liver disease.

Teaching & Supervision:

• Module leader for Diabetes Practice (MSc program)
• Supervises MD/PhD projects on metabolic dysfunction and bariatric surgery
• Contributes to Graduate Entry Medicine program

Labs/Teams:

Active in Swansea University Medical School’s Diabetes and Endocrinology research groups, collaborating with Prof Jeffrey Stephens on metabolic studies.